A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Clinical trial NCT06657768 · RECRUITING

Trial details

NCT number: NCT06657768
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Healthy

Start date: 2024-10-29
Primary completion: 2027-07-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.